Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sernova Corp (SVA.VN)

Sernova Corp (SVA.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sernova Corp 700 Collip Circle, The Stiller Centre Suite 114 London ON N6G 4X8 CAN

P: 519-858-5126

Description:

Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. It develops a commercially-viable treatment for insulin-dependent human diabetes and other metabolic, blood, and neurological diseases with therapeutic cells placed into its implanted, prevascularized and scalable medical device.

Key Statistics

Overview:

Market Capitalization, $K 432,574
Shares Outstanding, K 275,525
Annual Sales, $ 0 K
Annual Net Income, $ -6,966 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,459 K
60-Month Beta 1.45
% of Institutional Shareholders 0.05%

Growth:

1-Year Return 8.28%
3-Year Return 630.23%
5-Year Return 597.78%

Per-Share Information:

Latest Earnings Date 06/24/22
Earnings Per Share ttm -0.04
EPS Growth vs. Prev Year 0.00%
Dividend Payout Ratio 0.00%

SVA.VN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -59.05%
Return-on-Assets % -54.42%
Profit Margin % 0.00%
Debt/Equity 0.01
Price/Sales N/A
Price/Book 15.88
Book Value/Share 0.10
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar